搜尋





搜尋





市場行情
/
股票
/
dnli
/

Denali Therapeutics Inc

DNLI

添加自選

24.040USD

+0.470+1.99%

收盤 07-28 16:00（美東）報價延遲15分鐘

3.81B總市值

虧損本益比TTM

Denali Therapeutics Inc

24.040

+0.470+1.99%

概覽

財務

分析

公司

財務摘要利潤表資產負債表現金流量表

DNLI 利潤表

您可以在這裡找到Denali Therapeutics Inc的年度或季度收入報告，以深入了解Denali Therapeutics Inc的營運、管理效率和表現。

單季報

單季報+年報

單季報

年報

YOY

隱藏空白列

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

FY2018Q2

FY2018Q1

FY2017Q4

FY2017Q3

FY2017Q2

FY2017Q1

FY2016Q4

FY2016Q3

營業總收入

----

--0.00

----

--0.00

-100.00%0.00

-64.40%1.27M

460.45%294.12M

-16.61%35.14M

-17.83%10.28M

-32.66%3.56M

128.78%52.48M

431.88%42.14M

-96.05%12.51M

-43.73%5.29M

292.32%22.94M

119.84%7.92M

6681.14%316.81M

-30.95%9.39M

39.31%5.85M

-14.29%3.60M

-96.28%4.67M

1038.41%13.60M

154.67%4.20M

556.01%4.21M

--125.68M

--1.20M

--1.65M

--641.00K

----

--0.00

----

營業收入

----

--0.00

----

--0.00

-100.00%0.00

-64.40%1.27M

460.45%294.12M

-16.61%35.14M

-17.83%10.28M

-32.66%3.56M

128.78%52.48M

431.88%42.14M

-96.05%12.51M

-43.73%5.29M

292.32%22.94M

119.84%7.92M

6681.14%316.81M

-30.95%9.39M

39.31%5.85M

-14.29%3.60M

-96.28%4.67M

1038.41%13.60M

154.67%4.20M

556.01%4.21M

--125.68M

--1.20M

--1.65M

--641.00K

----

--0.00

----

營業費用

-5.65%137.36M

5.79%137.37M

11.57%137.43M

15.76%134.96M

10.08%145.58M

-2.06%129.85M

7.06%123.19M

-5.70%116.59M

-15.20%132.25M

14.65%132.57M

3.62%115.06M

8.56%123.64M

43.55%155.96M

29.00%115.63M

22.19%111.05M

34.38%113.90M

37.27%108.64M

23.23%89.64M

30.74%90.88M

26.27%84.76M

24.50%79.14M

16.51%72.74M

9.02%69.51M

0.24%67.12M

36.09%63.57M

22.52%62.43M

62.82%63.76M

13.43%66.96M

77.02%46.71M

116.46%50.95M

75.70%39.16M

161.57%59.03M

21.36%26.39M

19.03%23.54M

-27.95%22.29M

--22.57M

--21.74M

--19.78M

--30.93M

研發費用

-10.65%103.85M

-1.89%97.91M

3.78%101.95M

12.36%102.70M

8.61%116.23M

-7.44%99.79M

9.47%98.24M

-6.28%91.40M

-16.92%107.02M

17.04%107.80M

2.22%89.74M

5.16%97.52M

49.62%128.82M

35.70%92.11M

22.68%87.79M

41.13%92.74M

43.00%86.10M

23.99%67.88M

33.25%71.56M

23.63%65.71M

18.02%60.21M

6.19%54.74M

2.21%53.70M

2.44%53.15M

36.40%51.02M

29.17%51.55M

73.29%52.54M

-0.48%51.88M

79.66%37.40M

116.06%39.91M

63.76%30.32M

174.33%52.13M

12.72%20.82M

10.41%18.47M

-33.44%18.52M

--19.00M

--18.47M

--16.73M

--27.82M

折舊攤銷及損耗

17.09%3.76M

44.41%3.78M

70.21%3.86M

103.71%3.96M

48.57%3.21M

20.30%2.62M

2.35%2.27M

-15.01%1.94M

-78.48%2.16M

-46.79%2.18M

3.55%2.22M

10.28%2.29M

383.26%10.05M

95.37%4.09M

-2.10%2.14M

-5.99%2.07M

-1.38%2.08M

-1.27%2.09M

1.44%2.19M

2.75%2.20M

-0.05%2.11M

3.21%2.12M

14.07%2.16M

30.55%2.15M

-12.23%2.11M

-13.62%2.06M

-18.78%1.89M

-11.43%1.64M

181.38%2.40M

194.80%2.38M

199.10%2.33M

142.17%1.85M

16.83%854.00K

17.64%807.00K

94.01%778.00K

--766.00K

--731.00K

--686.00K

--401.00K

營業利潤

5.65%-137.36M

-5.79%-137.37M

-11.57%-137.43M

-15.76%-134.96M

-10.08%-145.58M

2.06%-129.85M

-8.25%-123.19M

-168.39%-116.59M

-9.47%-132.25M

-25.85%-132.57M

-5.87%-113.80M

377.59%170.48M

-81.68%-120.81M

-36.60%-105.34M

-25.58%-107.49M

0.65%-61.42M

6.63%-66.50M

-131.60%-77.12M

-42.38%-85.59M

-0.88%-61.82M

-18.77%-71.22M

522.59%244.08M

-19.86%-60.12M

2.37%-61.28M

-41.07%-59.97M

-177.30%-57.76M

-32.11%-50.16M

-9.38%-62.76M

-65.09%-42.51M

417.43%74.72M

-70.33%-37.96M

-154.26%-57.38M

-18.41%-25.75M

-19.03%-23.54M

27.95%-22.29M

---22.57M

---21.74M

---19.78M

---30.93M

淨非營業利息收入（費用）

利息收入

-29.05%9.09M

-40.51%9.14M

-33.32%10.73M

--11.04M

--12.81M

--15.36M

--16.09M

----

利息費用

-10.50%179.00K

10.00%220.00K

100.00%200.00K

--200.00K

--100.00K

----

特殊收入（費用）

----

--0.00

-100.00%0.00

--0.00

--14.54M

----

稅前利潤

3.40%-128.45M

-12.00%-128.45M

-18.39%-126.90M

-25.34%-124.12M

-30.62%-132.97M

3.98%-114.69M

-7.89%-107.19M

-154.00%-99.03M

7.27%-101.80M

-21.04%-119.44M

3.82%-99.35M

412.05%183.38M

-68.32%-109.78M

-30.13%-98.68M

-22.12%-103.30M

3.17%-58.77M

6.88%-65.22M

-130.86%-75.84M

-45.41%-84.59M

-3.43%-60.69M

-23.10%-70.04M

555.44%245.71M

-25.44%-58.17M

-0.05%-58.68M

-45.92%-56.90M

-169.58%-53.95M

-31.10%-46.37M

-7.17%-58.65M

-64.68%-38.99M

438.76%77.53M

-61.93%-35.37M

-147.24%-54.72M

-11.06%-23.68M

-18.25%-22.89M

28.64%-21.84M

---22.13M

---21.32M

---19.35M

---30.61M

所得稅

----

50.00%102.00K

----

126.67%68.00K

----

600.00%30.00K

--0.00

-100.00%0.00

----

98.96%-6.00K

--0.00

--27.00K

----

-169.87%-575.00K

-100.00%0.00

100.00%0.00

997.33%823.00K

149.56%56.00K

125.24%79.00K

---135.00K

--75.00K

---113.00K

---313.00K

----

除稅後利潤

3.40%-128.45M

-12.02%-128.55M

-18.39%-126.90M

-25.34%-124.12M

-30.62%-132.97M

3.95%-114.75M

-7.89%-107.19M

-154.00%-99.03M

7.27%-101.80M

-21.07%-119.47M

3.82%-99.35M

411.91%183.38M

-68.32%-109.78M

-31.11%-98.68M

-22.12%-103.30M

3.13%-58.79M

6.88%-65.22M

-130.73%-75.26M

-45.27%-84.59M

-3.29%-60.69M

-23.39%-70.04M

553.28%244.88M

-25.87%-58.23M

-0.72%-58.76M

-45.58%-56.76M

-169.68%-54.02M

-30.79%-46.26M

-6.60%-58.34M

-64.68%-38.99M

438.76%77.53M

-61.93%-35.37M

-147.24%-54.72M

-11.06%-23.68M

-18.25%-22.89M

28.64%-21.84M

---22.13M

---21.32M

---19.35M

---30.61M

持續經營利潤

3.40%-128.45M

-12.02%-128.55M

-18.39%-126.90M

-25.34%-124.12M

-30.62%-132.97M

3.95%-114.75M

-7.89%-107.19M

-154.00%-99.03M

7.27%-101.80M

-21.07%-119.47M

3.82%-99.35M

411.91%183.38M

-68.32%-109.78M

-31.11%-98.68M

-22.12%-103.30M

3.13%-58.79M

6.88%-65.22M

-130.73%-75.26M

-45.27%-84.59M

-3.29%-60.69M

-23.39%-70.04M

553.28%244.88M

-25.87%-58.23M

-0.72%-58.76M

-45.58%-56.76M

-169.68%-54.02M

-30.79%-46.26M

-6.60%-58.34M

-64.68%-38.99M

438.76%77.53M

-61.93%-35.37M

-147.24%-54.72M

-11.06%-23.68M

-18.25%-22.89M

28.64%-21.84M

---22.13M

---21.32M

---19.35M

---30.61M

歸属于母公司的淨利潤

3.40%-128.45M

-12.02%-128.55M

-18.39%-126.90M

-25.34%-124.12M

-30.62%-132.97M

3.95%-114.75M

-7.89%-107.19M

-154.00%-99.03M

7.27%-101.80M

-21.07%-119.47M

3.82%-99.35M

411.91%183.38M

-68.32%-109.78M

-31.11%-98.68M

-22.12%-103.30M

3.13%-58.79M

6.88%-65.22M

-130.73%-75.26M

-45.27%-84.59M

-3.29%-60.69M

-23.39%-70.04M

553.28%244.88M

-25.87%-58.23M

-0.72%-58.76M

-45.58%-56.76M

-169.68%-54.02M

-30.79%-46.26M

-6.60%-58.34M

-64.68%-38.99M

438.76%77.53M

-61.93%-35.37M

-147.24%-54.72M

-11.06%-23.68M

-18.25%-22.89M

28.64%-21.84M

---22.13M

---21.32M

---19.35M

---30.61M

歸屬普通股東的淨利潤

3.40%-128.45M

-12.02%-128.55M

-18.39%-126.90M

-25.34%-124.12M

-30.62%-132.97M

3.95%-114.75M

-7.89%-107.19M

-154.00%-99.03M

7.27%-101.80M

-21.07%-119.47M

3.82%-99.35M

411.91%183.38M

-68.32%-109.78M

-31.11%-98.68M

-22.12%-103.30M

3.13%-58.79M

6.88%-65.22M

-130.73%-75.26M

-45.27%-84.59M

-3.29%-60.69M

-23.39%-70.04M

553.28%244.88M

-25.87%-58.23M

-0.72%-58.76M

-45.58%-56.76M

-169.68%-54.02M

-30.79%-46.26M

-6.60%-58.34M

-64.68%-38.99M

438.76%77.53M

-61.93%-35.37M

-147.24%-54.72M

-11.06%-23.68M

-18.25%-22.89M

28.64%-21.84M

---22.13M

---21.32M

---19.35M

---30.61M

基本每股收益

11.38%-0.69

-8.60%-0.73

-16.35%-0.74

-23.43%-0.72

-13.97%-0.78

21.95%-0.67

12.36%-0.63

-143.83%-0.59

15.26%-0.68

-16.44%-0.86

13.72%-0.72

379.95%1.34

-51.25%-0.80

-20.48%-0.74

-20.41%-0.84

4.48%-0.48

8.24%-0.53

-130.25%-0.62

-28.26%-0.69

9.97%-0.50

-4.54%-0.58

462.21%2.04

-12.25%-0.54

9.02%-0.56

-35.01%-0.55

-168.40%-0.56

-27.79%-0.48

-3.70%-0.61

-55.27%-0.41

468.69%0.82

-42.49%-0.38

74.26%-0.59

88.82%-0.26

5.05%-0.22

28.64%-0.27

---2.29

---2.36

---0.23

---0.37

稀釋每股收益

11.38%-0.69

-8.60%-0.73

-16.35%-0.74

-23.43%-0.72

-13.97%-0.78

21.95%-0.67

12.36%-0.63

-145.08%-0.59

15.26%-0.68

-16.44%-0.86

13.72%-0.72

372.24%1.30

-51.25%-0.80

-20.48%-0.74

-20.41%-0.84

4.48%-0.48

8.24%-0.53

-134.00%-0.62

-28.26%-0.69

9.97%-0.50

-4.54%-0.58

422.23%1.81

-12.25%-0.54

9.02%-0.56

-35.01%-0.55

-168.40%-0.56

-27.79%-0.48

-3.70%-0.61

-55.27%-0.41

468.69%0.82

-42.49%-0.38

74.26%-0.59

88.82%-0.26

5.05%-0.22

28.64%-0.27

---2.29

---2.36

---0.23

---0.37

每股派息

--0.00

貨幣單位

--USD

審計意見

----

常見問題

如何在 TradingKey 上查看 Denali Therapeutics Inc 的利潤表？



先看總營收，再依序查看營業成本、毛利、營業費用、營業利益、稅前淨利、淨利和每股盈餘（EPS）。營收反映公司的業務規模，而各項獲利和利潤率則體現公司能否有效地將營收轉化為獲利。

季度利潤表和年度利潤表有什麼區別？



季度利潤表反映公司在一個為期三個月的財務季度內的經營表現，年度損益表則彙總整個財年的業績。季度數據適合用於觀察近期發展勢頭和季節性變化，年度數據則更適合評估長期成長、獲利能力和業務週期。

利潤表頁面中的同比是什麼意思？



同比（即年增率，YoY）是指將某項財務指標與上年同期進行比較，例如將本季度營收與去年同一季度的營收進行對比。與去年同期比較的數據有助於投資者觀察成長趨勢，同時減少正常季節性變化對分析的影響。

分析 DNLI 股票時，哪些利潤表指標最重要？



重要的指標包括營收成長、毛利、毛利率、營業利益、營業利益率、淨利、每股盈餘、研發費用、銷售及管理費用以及所得稅費用。投資者通常會綜合分析這些指標，以判斷公司是否正在成長、有效控制成本並提升獲利能力。

Denali Therapeutics Inc 全年的淨利潤是多少？



Denali Therapeutics Inc 2025 財年淨利潤為 -512.54M。

Denali Therapeutics Inc 上一季度的淨利潤是多少？



Denali Therapeutics Inc 最近一個季度的淨利潤為 -128.45M。

Denali Therapeutics Inc 年度營業利潤是多少？



Denali Therapeutics Inc 2025 財年的營業利潤為 -555.34M。

每股收益與利潤表有什麼關係？



每股收益（EPS）通常以淨利潤除以流通在外的股份數量計算，用於衡量公司平均每股創造的利潤。分析 EPS 時，還應結合股本變化、利潤率、現金流和估值指標進行綜合判斷。